Selectis Health (GBCS) Liabilities and Shareholders Equity (2011 - 2025)

Selectis Health (GBCS) has 15 years of Liabilities and Shareholders Equity data on file, last reported at $32.6 million in Q4 2025.

• Quarterly Liabilities and Shareholders Equity fell 2.6% year-over-year to $32.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $134.0 million (down 6.71% YoY) and the FY2025 annual result came in at $32.6 million, down 2.6% from the prior year.
• Liabilities and Shareholders Equity eased to $32.6 million in Q4 2025 per GBCS's latest filing, from $33.3 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $48.7 million in Q1 2023, with the low at $32.6 million in Q4 2025.
• Average Liabilities and Shareholders Equity over 5 years is $41.1 million, with a median of $42.4 million recorded in 2022.
• Year-over-year, Liabilities and Shareholders Equity grew 11.73% in 2021 and fell 21.75% in 2024.
• Selectis Health's Liabilities and Shareholders Equity stood at $46.9 million in 2021, then retreated by 9.45% to $42.5 million in 2022, then slipped by 4.28% to $40.7 million in 2023, then retreated by 17.76% to $33.4 million in 2024, then dropped by 2.6% to $32.6 million in 2025.
• Business Quant data shows GBCS's Liabilities and Shareholders Equity at $32.6 million in Q4 2025, $33.3 million in Q3 2025, and $33.6 million in Q2 2025.